Analyst Profile

Followed by 473 followers
.
Douglas Tsao

Douglas Tsao

H.C. Wainwright
Wall Street Analyst
#2,149 out of 8,160 Wall Street Analysts
#4,635 out of 24,427 experts

Success Rate

39%
161 out of 410 transactions made a profit

Average Return

+3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Douglas Tsao's trades since 2014 and holding each position for 1 Year would result in 39.27% of your transactions generating a profit, with an average return of 3.7% per rating.

Stock Rating Distribution

852Ratings
76.29% Buy
22.18% Hold
1.53% Sell
Distribution of Douglas Tsao's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Cabaletta Bio, Inc.
(CABA)
Rating:Buy
Date:Oct 12, 2022 - Today
Return:+490.20%
The most profitable rating made by Douglas Tsao

Douglas Tsao's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
~FRX
Forest Labs
Feb 19, 2014
Hold
Assigned
3Ratings
0.00%
CVD
Covance Inc
Mar 07, 2014
Sell
Assigned
5Ratings
0.00%
PRXL
Parexel
Apr 28, 2016
Buy
Reiterated
4Ratings
0.00%
FOMX
Foamix Pharma
Aug 10, 2016
Buy
Reiterated
2Ratings
0.00%
PETX
Aratana
Aug 10, 2016
Buy
Reiterated
2Ratings
0.00%
Arcturus Therapeutics
Nov 16, 2016
Sell
Reiterated
$2.00
(-89.53% Downside)
5Ratings
0.00%
Charles River Labs
Nov 30, 2016
Hold
Upgraded
5Ratings
0.00%
Jazz Pharmaceuticals
Jan 18, 2017
Buy
Reiterated
$200.00
(27.19% Upside)
7Ratings
0.00%
CLCD
CoLucid Pharmaceuticals
Jan 23, 2017
Hold
Downgraded
2Ratings
0.00%
Viatris
May 22, 2017
Buy
Upgraded
$50.00
(347.63% Upside)
6Ratings
0.00%
List of latest recommendations made by Douglas Tsao. Click to expand and see Douglas Tsao's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >